Mice lacking pro-opiomelanocortin are sensitive to high-fat feeding but respond normally to the acute anorectic effects of peptide-YY(3-36).

Inactivating mutations of the pro-opiomelanocortin (POMC) gene in both mice and humans leads to hyperphagia and obesity. To further examine the mechanisms whereby POMC-deficiency leads to disordered energy homeostasis, we have generated mice lacking all POMC-derived peptides. Consistent with a previously reported model, Pomc(-/-) mice were obese and hyperphagic. They also showed reduced resting oxygen consumption associated with lowered serum levels of thyroxine. Hypothalami from Pomc(-/-) mice showed markedly increased expression of melanin-concentrating hormone mRNA in the lateral hypothalamus, but expression of neuropeptide Y mRNA in the arcuate nucleus was not altered. Provision of a 45% fat diet increased energy intake and body weight in both Pomc(-/-) and Pomc(+/-) mice. The effects of leptin on food intake and body weight were blunted in obese Pomc(-/-) mice whereas nonobese Pomc(-/-) mice were sensitive to leptin. Surprisingly, we found that Pomc(-/-) mice maintained their acute anorectic response to peptide-YY(3-36) (PYY(3-36)). However, 7 days of PYY(3-36) administration had no effect on cumulative food intake or body weight in wild-type or Pomc(-/-) mice. Thus, POMC peptides seem to be necessary for the normal response of energy balance to high-fat feeding, but not for the acute anorectic effect of PYY(3-36) or full effects of leptin on feeding. The finding that the loss of only one copy of the Pomc gene is sufficient to render mice susceptible to the effects of high fat feeding emphasizes the potential importance of this locus as a site for gene-environment interactions predisposing to obesity.

[1]  S. Pinnock,et al.  Corticosterone differentially modulates expression of corticotropin releasing factor and arginine vasopressin mRNA in the hypothalamic paraventricular nucleus following either acute or repeated restraint stress , 2001, The European journal of neuroscience.

[2]  S. Bloom,et al.  The central melanocortin system affects the hypothalamo-pituitary thyroid axis and may mediate the effect of leptin. , 2000, The Journal of clinical investigation.

[3]  A. Vincent,et al.  Autoimmune Disorders of Neuronal Potassium Channels , 2003, Annals of the New York Academy of Sciences.

[4]  S. Bloom,et al.  Gut and mind , 2003, Gut.

[5]  R. Cone,et al.  Independent and additive effects of central POMC and leptin pathways on murine obesity. , 1997, Science.

[6]  S. Woods,et al.  Central nervous system control of food intake , 2000, Nature.

[7]  M. Nakazato,et al.  Differential regulation of melanin-concentrating hormone and orexin genes in the agouti-related protein/melanocortin-4 receptor system. , 2000, Biochemical and biophysical research communications.

[8]  S. O’Rahilly,et al.  Minireview: human obesity-lessons from monogenic disorders. , 2003, Endocrinology.

[9]  H. Iwaasa,et al.  Chronic intracerebroventricular infusion of MCH causes obesity in mice. Melanin-concentrating hormone. , 2003, American journal of physiology. Endocrinology and metabolism.

[10]  R. Cone,et al.  Disproportionate Inhibition of Feeding in Ay Mice by Certain Stressors: A Cautionary Note , 2000, Neuroendocrinology.

[11]  M. Low,et al.  Activation of Central Melanocortin Pathways by Fenfluramine , 2002, Science.

[12]  M. Low,et al.  Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus , 2001, Nature.

[13]  J G Ratcliffe,et al.  Direct measurement of the precursors of adrenocorticotropin in human plasma by two-site immunoradiometric assay. , 1988, The Journal of clinical endocrinology and metabolism.

[14]  S. O’Rahilly,et al.  Acute effects of PYY3-36 on food intake and hypothalamic neuropeptide expression in the mouse. , 2003, Biochemical and biophysical research communications.

[15]  S. Gammeltoft,et al.  A role for melanin-concentrating hormone in the central regulation of feeding behaviour , 1996, Nature.

[16]  S. Leibowitz,et al.  Neuropeptide Y chronically injected into the hypothalamus: A powerful neurochemical inducer of hyperphagia and obesity , 1986, Peptides.

[17]  B. Lowell,et al.  Mice lacking melanin-concentrating hormone are hypophagic and lean , 1998, Nature.

[18]  R. Palmiter,et al.  A metabolic defect promotes obesity in mice lacking melanocortin-4 receptors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[19]  R. Steiner,et al.  Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus. , 1997, Endocrinology.

[20]  M. Low,et al.  Lack of Proopiomelanocortin Peptides Results in Obesity and Defective Adrenal Function but Normal Melanocyte Pigmentation in the Murine C57BL/6 Genetic Background , 2003, Annals of the New York Academy of Sciences.

[21]  John Blangero,et al.  A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2 , 1997, Nature Genetics.

[22]  Rachel L. Batterham,et al.  Gut hormone PYY3-36 physiologically inhibits food intake , 2002, Nature.

[23]  J. Bue-Valleskey,et al.  The role of neuropeptide Y in the antiobesity action of the obese gene product , 1995, Nature.

[24]  C. Saper,et al.  Expression of melanocortin 4 receptor mRNA in the central nervous system of the rat , 2003, The Journal of comparative neurology.

[25]  R. Cone,et al.  Melanocortin-4 receptor is required for acute homeostatic responses to increased dietary fat , 2001, Nature Neuroscience.

[26]  J. Nadeau,et al.  Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function , 1993, Cell.

[27]  B. Lowell,et al.  Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance. , 2001, The Journal of clinical investigation.

[28]  C. Saper,et al.  The Need to Feed Homeostatic and Hedonic Control of Eating , 2002, Neuron.

[29]  A. G. Roseberry,et al.  Transgenic Mice Expressing Green Fluorescent Protein under the Control of the Melanocortin-4 Receptor Promoter , 2003, The Journal of Neuroscience.

[30]  S. Woods,et al.  Leptin Increases Hypothalamic Pro-opiomelanocortin mRNA Expression in the Rostral Arcuate Nucleus , 1997, Diabetes.

[31]  K. Clément,et al.  A genome-wide scan for human obesity genes reveals a major susceptibility locus on chromosome 10 , 1998, Nature Genetics.

[32]  R. Palmiter,et al.  Response of melanocortin–4 receptor–deficient mice to anorectic and orexigenic peptides , 1999, Nature Genetics.

[33]  A. Grüters,et al.  Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans , 1998, Nature Genetics.

[34]  L. Almasy,et al.  Normal variation in leptin levels in associated with polymorphisms in the proopiomelanocortin gene, POMC. , 1999, The Journal of clinical endocrinology and metabolism.

[35]  Mohammad A Ghatei,et al.  Inhibition of food intake in obese subjects by peptide YY3-36. , 2003, The New England journal of medicine.

[36]  J. Flier,et al.  Transcriptional regulation of the thyrotropin-releasing hormone gene by leptin and melanocortin signaling. , 2001, The Journal of clinical investigation.

[37]  R. Cone,et al.  Induction of neuropeptide Y gene expression in the dorsal medial hypothalamic nucleus in two models of the agouti obesity syndrome. , 1997, Molecular endocrinology.

[38]  L. Yaswen,et al.  Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin , 1999, Nature Medicine.

[39]  E. Hutchinson,et al.  Characterization of a Serine Protease that Cleaves Pro-γ-Melanotropin at the Adrenal to Stimulate Growth , 2001, Cell.

[40]  Yue Feng,et al.  Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass , 2000, Nature Genetics.

[41]  R. Cone,et al.  Targeted Disruption of the Melanocortin-4 Receptor Results in Obesity in Mice , 1997, Cell.